arrow
A

Adel Mandl

metabolic diseases branch
H指数:10
被引数:384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 2 Study of Cabozantinib (XL184) with Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas (ETCTN10315)

卡博替尼(XL184)联合纳武利尤单抗和伊匹木单抗治疗低分化神经内分泌癌的2期研究(ETCTN10315)

2026-04-100
OA
Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant

蛇皮葡萄提取物在生物化学复发性前列腺癌中的应用:一项针对携带SOD2 Ala/Ala变异患者的随机、安慰剂对照、生物标志物富集试验

2025-05-050
PRE